Reimagining what it means to deliver truly personalised care in the next decade.

Precision medicine has reached an inflection point. The scientific breakthroughs exist. The technologies exist. The data exists. From multi-omics and advanced diagnostics to artificial intelligence and predictive analytics, the tools needed to transform healthcare are advancing rapidly. 

The challenge now is implementation - how do we move beyond discovery to deliver precision medicine at scale?

This flagship Nature conference explores what it takes to embed precision approaches into real-world clinical practice and health systems, bringing together leaders across science, medicine, industry and policy to address the practical barriers standing between breakthrough discovery and real-world impact.

The conversations driving the field forward

The question is no longer whether precision medicine works. The question is:

  • How do we implement it?

  • How do we scale it?

  • How do we ensure equitable access?

  • How do we integrate AI, multi-omics and advanced diagnostics into routine care?

  • How do we translate innovation into measurable patient benefit?

These are the questions this conference is designed to answer. You will not find them addressed with the same depth, cross-sector perspective and practical rigour anywhere else.

What makes this conference different

Rather than focusing on a single technology or discipline, Reframing Precision Medicine: Innovation to Implementation takes a cross-sector view across the full human life course, bringing together every voice needed to move from discovery to delivery.

Translating discovery into clinical practice

Explore how leading researchers, clinicians and industry innovators are closing the gap between what is scientifically possible and what can be implemented safely, responsibly and at scale.

AI and data-driven decision making

Gain insight into how AI can support better clinical decisions without losing sight of patient safety, transparency and real-world usability.

Multi-omics and advanced diagnostics

Examine how new technologies are informing earlier detection, more targeted therapies and more personalised patient pathways. We will go beyond technical capability to ask how these tools can be validated, integrated and used meaningfully across healthcare systems.

Health system adoption and implementation

Hear how health systems are moving from pilots and proof-of-concept models towards scalable approaches that can be adopted across real-world care settings.

Policy, regulation and reimbursement

Explore the regulatory, reimbursement and governance questions shaping adoption, from approval pathways and evidence standards to sustainable funding models.

Equity, access and patient outcomes

Examine how access, representation, affordability and health system capacity influence outcomes, and consider how precision medicine can be implemented in ways that reduce, rather than widen, inequalities.

This conference will move beyond what is emerging in the lab, addressing the questions needed to shape the future of personalised care - and what is required to make it the norm, not the exception.

Whether you work in genomics, AI, clinical practice, diagnostics, drug development or health policy, the agenda is built around the answers you need most.

View agenda (opens in a new tab)
Register now (opens in a new tab)

Who you will meet:

  • Academics, Academics, Academics, Academics

    Academic and clinical researchers across omics, AI, epidemiology and clinical sciences

  • Clinicians,Clinicians,Clinicians,Clinicians

    Clinicians and healthcare professionals shaping care pathways and treatment decisions

  • Policy,Policy,Policy,Policy

    Policy makers, regulators and public health leaders designing frameworks for precision health

  • Biotech,Biotech,Biotech,Biotech

    Industry leaders from biotech, pharma, diagnostics, digital health and AI

  • Data scientists,Data scientists,Data scientists,Data scientists

    Data scientists, bioinformaticians and engineers building platforms and tools

Top reasons to attend

Understand

how multi-omics, artificial intelligence and big data are being combined to drive real-time, personalised decisions in the clinic.

Explore

case studies where biomarkers, early detection and targeted therapies are reshaping care across oncology, neurology, immunology, nutrition and more.

Discuss

policy, regulatory and ethical frameworks needed to scale precision medicine responsibly.

Uncover

how digital epidemiology, real-world data and patient-reported outcomes can complement traditional clinical evidence.

Learn

practical approaches to tackling algorithmic bias, data gaps and under-representation in global cohorts and biobanks.

Connect

with leaders from across the Nature Portfolio community and beyond to build new collaborations.

What you’ll take away:

A sharper view of where precision medicine is heading

Hear how multi-omics, artificial Intelligence and big data are converging in the clinic, from early detection and risk prediction to targeted therapies and monitoring.

Practical insights on implementation, not just innovation

Learn from case studies that show what works, what does not and what is needed to move beyond pilots and proof-of-concept projects.

A deeper understanding of equity, bias and inclusion

Explore how global biobanks, diverse cohorts and fair artificial Intelligence models can support more robust and inclusive precision health.

Clarity on policy, governance and ethics

Discuss frameworks for responsible artificial Intelligence in medicine, data governance and regulation, with perspectives from researchers, clinicians and policy makers.

Connections across disciplines and sectors

Meet experts from academic research, clinical practice, industry, data science and public health who are all working on the same challenge: making precision medicine usable and sustainable at scale.

Request updates (opens in a new tab)
View preliminary agenda (opens in a new tab)